9 May 2022 - Before the enactment of the Patient Protection and Affordable Care Act in 2010, experimentation with Medicare or ...
7 May 2022 - Randomised, controlled trials remain underutilised within the Medicaid program, even though state Medicaid programs regularly implement new ...
15 April 2022 - On 21 March 2022, Johnson & Johnson became the 16th pharmaceutical manufacturer to restrict the delivery of ...
8 October 2021 - In this cross-sectional study of 216 drugs granted accelerated approval from 1992 through 2020, relative to all ...
19 June 2021 - President Biden has made reforms intended to “protect and strengthen Medicaid” a centrepiece of his health policy ...
26 October 2020 - The new regulations would allow beneficiaries to receive a vaccine under “emergency authorisation” at no cost. ...
9 August 2020 - For well over a decade policymakers have declared the healthcare system is moving towards value-based pricing ...
22 June 2020 - On Wednesday, June 17, the Centers for Medicare and Medicaid Services proposed a series of reforms ...
1 June 2020 - Delays in market entry of generic drugs are common. ...
3 April 2020 - As the prescription drug pipeline fills with very high-cost gene therapies and specialty drugs, affordability and access ...
31 January 2020 - The Trump administration on Thursday unveiled a powerful new tool for states to rein in prescription ...
16 October 2019 - Despite guidance from the federal government, most state Medicaid programs continue to deny hepatitis C treatments ...
26 June 2019 - State Plan Amendment permits Louisiana to negotiate supplemental drug rebates to assist the state in controlling expenditures ...
22 May 2019 - Over the past decade, both public and private payers have increasingly sought to develop payment policies that ...
8 April 2019 - Pazdur chastises PD-1/PD-L1 pharmas for losing sight of patients. ...